Cargando…

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Bahl, Kapil, Senn, Joe J., Yuzhakov, Olga, Bulychev, Alex, Brito, Luis A., Hassett, Kimberly J., Laska, Michael E., Smith, Mike, Almarsson, Örn, Thompson, James, Ribeiro, Amilcar (Mick), Watson, Mike, Zaks, Tal, Ciaramella, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372314/ https://www.ncbi.nlm.nih.gov/pubmed/35921837 http://dx.doi.org/10.1016/j.ymthe.2022.07.013

Ejemplares similares

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
por: Bahl, Kapil, et al.
Publicado: (2017)

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
por: Hassett, Kimberly J., et al.
Publicado: (2019)

Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
por: Liang, Frank, et al.
Publicado: (2017)

Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
por: Lindgren, Gustaf, et al.
Publicado: (2017)

Corrigendum: Induction of Robust B Cell Responses After Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
por: Lindgren, Gustaf, et al.
Publicado: (2019)

Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth
por: Moyo, Nathifa, et al.
Publicado: (2020)

Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes
por: Rajesh Kumar, Subaschandrabose, et al.
Publicado: (2017)

LABEL: Fast and Accurate Lineage Assignment with Assessment of H5N1 and H9N2 Influenza A Hemagglutinins
por: Shepard, Samuel S., et al.
Publicado: (2014)

Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice
por: Hekele, Armin, et al.
Publicado: (2013)

The Length of N-Glycans of Recombinant H5N1 Hemagglutinin Influences the Oligomerization and Immunogenicity of Vaccine Antigen
por: Macioła, Agnieszka Katarzyna, et al.
Publicado: (2017)

Evaluation of Live Attenuated H7N3 and H7N7 Vaccine Viruses for Their Receptor Binding Preferences, Immunogenicity in Ferrets and Cross Reactivity to the Novel H7N9 Virus
por: Xu, Qi, et al.
Publicado: (2013)

Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
por: Zhang, Zhegang, et al.
Publicado: (2022)

Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge
por: kumar, Subaschandrabose Rajesh, et al.
Publicado: (2015)

Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune mice
por: Moise, Leonard, et al.
Publicado: (2022)

Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus
por: Kim, Jin Il, et al.
Publicado: (2020)

The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards
por: Furmanski, Martin
Publicado: (2015)

The t + n + n System and 5H
por: Meister, M, et al.
Publicado: (2003)

Human Avian Influenza A H5N1, H7N9, H10N8 and H5N6 Virus Infection
por: Lu, Pu-Xuan, et al.
Publicado: (2015)

Meta-Analysis of the Immunogenicity and Tolerability of Pandemic Influenza A 2009 (H1N1) Vaccines
por: Manzoli, Lamberto, et al.
Publicado: (2011)

Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates
por: Fan, Shufang, et al.
Publicado: (2009)

Construction of recombinant baculoviruses expressing hemagglutinin of H5N1 avian influenza and research on the immunogenicity
por: Ge, Jingping, et al.
Publicado: (2016)

Intranasal administration of immunogenic poly-epitope from influenza H1N1 and H3N2 viruses adjuvanted with chitin and chitosan microparticles in BALB/c mice
por: Sadeghi, Sahar, et al.
Publicado: (2021)

Complete Genome Sequence of Avian Influenza Virus A/chicken/Jiangsu/1001/2013(H5N2), Demonstrating Continuous Reassortance of H5N2 in China
por: Mi, Zhiqiang, et al.
Publicado: (2013)

Highly pathogenic avian influenza virus incursions of subtype H5N8, H5N5, H5N1, H5N4, and H5N3 in Germany during 2020-21
por: King, Jacqueline, et al.
Publicado: (2022)

Reply to “The 1977 H1N1 Influenza Virus Reemergence Demonstrated Gain-of-Function Hazards”
por: Rozo, Michelle, et al.
Publicado: (2015)

Effects of Size and Surface Properties of Nanodiamonds on the Immunogenicity of Plant-Based H5 Protein of A/H5N1 Virus in Mice
por: Ho, Thuong Thi, et al.
Publicado: (2021)

Return of pandemic H1N1 influenza virus
por: Sherbany, Hilda, et al.
Publicado: (2014)

In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential
por: Muñoz-Medina, José Esteban, et al.
Publicado: (2015)

Immunogenicity of influenza H1N1 vaccination in mixed connective tissue disease: effect of disease and therapy
por: Miossi, Renata, et al.
Publicado: (2013)

Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis
por: Kapetanovic, Meliha C, et al.
Publicado: (2014)

Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design
por: De Groot, Anne S., et al.
Publicado: (2013)

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models
por: Rekstin, Andrey, et al.
Publicado: (2014)

Genetic Characteristics and Immunogenicity of Pandemic H1N1 Influenza Virus Isolate from Pig in Korea
por: Moon, Hyoung Joon, et al.
Publicado: (2016)

Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice
por: Choi, Eun-Jin, et al.
Publicado: (2017)

Disulfide isomerase ERp57 improves the stability and immunogenicity of H3N2 influenza virus hemagglutinin
por: Wu, Jialing, et al.
Publicado: (2020)

Immunogenicity of H5N1 influenza vaccines in elderly adults: a systematic review and meta-analysis
por: Zhang, Ke, et al.
Publicado: (2020)

Evolutionary Dynamics and Emergence of Panzootic H5N1 Influenza Viruses
por: Vijaykrishna, Dhanasekaran, et al.
Publicado: (2008)

2754. Phase 1 Trial of an mRNA-Based Combination Vaccine Against hMPV and PIV3
por: Shaw, Christine, et al.
Publicado: (2019)

Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken
por: Zhang, Yun, et al.
Publicado: (2017)

The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study
por: Wei, Sung-Hsi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tdlefmdhkqqc9f27bkbjck2jkj